| Long-Term Effects of COVID-19 | Lifetime | 59 | US 16 | 99.14 |
| Community Health and Development | Lifetime | 21 | US 18 | 99.08 |
| Homelessness and Social Issues | Lifetime | 66 | US 47 | 99.20 |
| COVID-19 and Mental Health | Lifetime | 148 | US 32 | 98.44 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | Lifetime | 92 | US 39 | 98.78 |
| Health, psychology, and well-being | Lifetime | 65 | US 27 | 98.75 |
| Musculoskeletal pain and rehabilitation | Lifetime | 381 | US 139 | 98.78 |
| School Health and Nursing Education | Lifetime | 87 | US 44 | 97.87 |
| Psychosomatic Disorders and Their Treatments | Lifetime | 193 | US 69 | 98.39 |
| Substance Abuse Treatment and Outcomes | Lifetime | 201 | US 139 | 98.54 |
| Health Policy Implementation Science | Lifetime | 206 | US 99 | 97.79 |
| Mental Health and Patient Involvement | Lifetime | 140 | US 52 | 97.30 |
| Smoking Behavior and Cessation | Lifetime | 251 | US 182 | 97.56 |
| Effects of Vibration on Health | Lifetime | 105 | US 43 | 96.89 |
| Workplace Health and Well-being | Lifetime | 259 | US 57 | 97.01 |
| Human Health and Disease | Lifetime | 531 | US 33 | 94.34 |
| Genetic Neurodegenerative Diseases | Lifetime | 966 | US 351 | 95.31 |
| Optimism, Hope, and Well-being | Lifetime | 235 | US 135 | 94.87 |
| Resilience and Mental Health | Lifetime | 694 | US 360 | 94.67 |
| Behavioral and Psychological Studies | Lifetime | 619 | US 483 | 94.59 |
| Multimedia Communication and Technology | Lifetime | 857 | US 214 | 90.63 |
| Parental Involvement in Education | Lifetime | 970 | US 645 | 89.98 |
| Myofascial pain diagnosis and treatment | Lifetime | 990 | US 252 | 87.25 |
| Blood donation and transfusion practices | Lifetime | 915 | US 343 | 84.70 |
| Youth Substance Use and School Attendance | Lifetime | 530 | US 294 | 82.43 |
| Gambling Behavior and Treatments | Lifetime | 919 | US 326 | 80.03 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | 2021-2025 | 7 | US 2 | 99.08 |
| Long-Term Effects of COVID-19 | 2021-2025 | 91 | US 24 | 98.76 |
| Homelessness and Social Issues | 2021-2025 | 22 | US 15 | 98.40 |
| COVID-19 and Mental Health | 2021-2025 | 140 | US 19 | 98.29 |
| Health, psychology, and well-being | 2021-2025 | 14 | US 6 | 97.56 |
| Substance Abuse Treatment and Outcomes | 2021-2025 | 215 | US 136 | 94.61 |
| Community Health and Development | 2021-2025 | 89 | US 42 | 90.13 |
| Health disparities and outcomes | 2021-2025 | 983 | US 342 | 89.99 |
| Musculoskeletal pain and rehabilitation | 2021-2025 | 976 | US 239 | 91.00 |
| Resilience and Mental Health | 2021-2025 | 509 | US 126 | 86.11 |
| Geriatric Care and Nursing Homes | 2021-2025 | 649 | US 261 | 88.52 |
| Olfactory and Sensory Function Studies | 2021-2025 | 725 | US 157 | 80.54 |
| Genetic Neurodegenerative Diseases | 2021-2025 | 920 | US 218 | 79.87 |
| Mental Health and Patient Involvement | 2021-2025 | 593 | US 85 | 78.26 |
| Psychosomatic Disorders and Their Treatments | 2021-2025 | 867 | US 177 | 77.08 |
| Workplace Health and Well-being | 2021-2025 | 732 | US 87 | 75.96 |
| Urban, Neighborhood, and Segregation Studies | 2021-2025 | 940 | US 498 | 42.22 |
